StonvexLoading…
StonvexStonvexStonvexCore line items from EOSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $114.20M | $15.61M | $16.38M | $17.92M |
Operating Income | $-259.27M | $-175.20M | $-152.94M | $-221.26M |
Net Income | $-969.65M | $-685.87M | $-229.51M | $-229.81M |
EPS (Diluted) | $-6.69 | $-4.55 | $-1.81 | $-3.68 |
Total Assets | $885.20M | $260.32M | $186.49M | $106.79M |
Total Liabilities | $1.76B | $842.09M | $297.29M | $239.50M |
Cash & Equivalents | $567.99M | $74.29M | $69.47M | $17.08M |
Free Cash Flow OCF − CapEx | $-264.97M | $-187.09M | $-174.34M | $-216.93M |
Shares Outstanding | 337.13M | 221.79M | 199.13M | 82.65M |